scispace - formally typeset
Y

Yuhei Kawano

Researcher at Teikyo University

Publications -  35
Citations -  1348

Yuhei Kawano is an academic researcher from Teikyo University. The author has contributed to research in topics: Blood pressure & Essential hypertension. The author has an hindex of 11, co-authored 35 publications receiving 774 citations. Previous affiliations of Yuhei Kawano include Kawasaki Medical School.

Papers
More filters
Journal ArticleDOI

The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

TL;DR: The story of the life and times of Toshihiko Umemura and his family in the years leading up to and including his death.
Journal ArticleDOI

Diagnostic value of carotid intima–media thickness and plaque score for predicting target organ damage in patients with essential hypertension

TL;DR: Age and all carotid ultrasonographical parameters were significantly associated with albuminuria, retinal arteriosclerosis, and left ventricular mass index, and high-sensitivity CRP was significantly correlated with retinopathy and LVH.
Journal ArticleDOI

Association of single nucleotide polymorphisms in endothelin family genes with the progression of atherosclerosis in patients with essential hypertension

TL;DR: Of the endothelin-related genes, EDNRB-rs5351 was the most susceptible SNP associated with atherosclerosis in male hypertensives, and the genetic background may be involved in the progression of atherosclerotic changes in EHT patients.
Journal ArticleDOI

Left ventricular diastolic dysfunction in patients with chronic renal failure: impact of diabetes mellitus.

TL;DR: The present study was designed to investigate the impact of diabetic nephropathy on LV diastolic dysfunction, independent of LV hypertrophy, in CRF patients.
Journal ArticleDOI

Effective uric acid-lowering treatment for hypertensive patients with hyperuricemia.

TL;DR: The UA-lowering effects of the low-dose combination of the UA synthesis inhibitor and uricosuric agent were greater than those of the standard dose of each agent alone and may be more effective at improving vascular function than theUA synthesis inhibitor.